NFKB1 and early-onset autosomal dominant Alzheimer disease: Disturbances of the gut microbiota may worsen signs of Alzheimer’s disease by activating signalling pathways such as the TLR4/NF-κB, ROS/JNK and NF-κB/BACE1 pathways; inhibiting these pathways with anthocyanins was suggested to decrease neuroinflammation and Alzheimer’s pathology [175].